Ankle exoskeleton aims to boost mobility in seniors
NCT ID NCT06284525
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested whether an ankle exoskeleton that provides resistance and biofeedback can improve walking in older adults with sarcopenia (age-related muscle loss). Nine participants aged 65–85 completed the trial. Researchers measured changes in walking distance, energy use, and ankle strength. The goal is to see if wearable devices can help older people move more easily.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ankle exoskeleton device with resistance and biofeedback
- What this could lead to
- If it works, this could point toward a simple wearable device to help older adults walk better and reduce fall risk.
- What could go wrong
- This is a very small early-phase trial with only 9 participants, so results may not apply to everyone. The device may not provide meaningful benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northern Arizona University
Flagstaff, Arizona, 86011, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can surgery for stomach or esophageal cancer cloud the mind?